Direct determination of the influence of the cell cycle on the survival of tumor cells exposed to cytotoxic antibodies.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000008:administration & dosage*; D002453:Cell Cycle / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D003609:Dactinomycin / Q000494:pharmacology; D007167:Immunotherapy; D008558:Melphalan / Q000494:pharmacology; D051379:Mice; D009101:Multiple Myeloma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy
D000912:Antibodies, Neoplasm; D003609:Dactinomycin; D008558:Melphalan